drugset / Trial / NCT07560475
Exploratory Study of SHR-A1811 Via Different Administration Routes in Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
An Exploratory Study on the Efficacy and Safety of Different Administration Routes of SHR-A1811 in the Treatment of HER2-Positive Advanced Breast Cancer
Timeline
- Start
- 2026-06-10
- Primary completion
- 2028-12-31
- Completion
- 2029-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trastuzumab Rezetecan | Monoclonal antibody | — | — |